Health · 3 views
Safety of Controversial Vasculitis Drug Bolstered in Dedicated Trial
(MedPage Today) -- ORLANDO -- Interim results from a prospective trial designed to evaluate safety of avacopan (Tavneos), the embattled drug for antineutrophil cytoplasmic antibody-associated vasculitis (AAV), indicated that the product…
Summary
(MedPage Today) -- ORLANDO -- Interim results from a prospective trial designed to evaluate safety of avacopan (Tavneos), the embattled drug for antineutrophil cytoplasmic antibody-associated vasculitis (AAV), indicated that the product could
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Researchers identify blood-based biomarkers that could help personalize treatment for autoimmune diabetesContinue reading
- Q&A: Researcher investigates pharmacological approaches to breast cancer preventionContinue reading
- Trial Stopped Early for Superiority of LBBP-Tuned PacemakersContinue reading
- Yoga-based cardiac rehab improved quality of life in people living with heart failureContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow